The development and validation of a nocturnal gastro-oesophageal reflux disease symptom severity and impact questionnaire for adults

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 4, 2010, Pages 591-602

  Spiegel, B M ^a   Roberts, L ^b   Mody, R ^c   Harding, G ^b   Kothari Talwar, S ^c   Kahrilas, P J ^d   Camilleri, M L ^e   Dabbous, O ^c   Revicki, D A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNITED BIOSOURCE CORPORATION   (United States)

^c Takeda Pharmaceuticals International Inc   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOATING; CAUCASIAN; CONSTRUCT VALIDITY; CRONBACH ALPHA COEFFICIENT; DISEASE SEVERITY; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; INTERNAL CONSISTENCY; INTERVIEW; LOWER ABDOMINAL PAIN; MAJOR CLINICAL STUDY; MALE; MEDICAL OUTCOMES STUDY 12 ITEM SLEEP SCALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA; NOCTURNAL GASTRO-OESOPHAGEAL REFLUX DISEASE SYMPTOM SEVERITY AND IMPACT QUESTIONNAIRE; PATIENT ASSESSMENT OF GASTROINTESTINAL DISORDERS SYMPTOM SEVERITY INDEX; PATIENT ASSESSMENT OF UPPER GASTROINTESTINAL DISORDERS QUALITY OF LIFE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; REPRODUCIBILITY; SLEEP DISORDER; STOMACH PARESIS; SYMPTOM; UPPER ABDOMINAL PAIN; VOMITING;

ADULT; AGED; CIRCADIAN RHYTHM; FACTOR ANALYSIS, STATISTICAL; FEMALE; FOCUS GROUPS; GASTROESOPHAGEAL REFLUX; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS;

EID: 77954717037     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04385.x     Document Type: Article

References (29)

1. Camilleri M, Dubois D, Coulie B, et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol 2005 3:543 552.
2. Dubois RW, Aguilar D, Fass R, et al. Consequences of frequent nocturnal gastro-oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity. Aliment Pharmacol Ther 2007 25:487 500.
3. Katz PO, Koch FK, Ballard ED, et al. Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms. Aliment Pharmacol Ther 2007 25:197 205.
4. Shaker R. Nighttime GERD: clinical implications and therapeutic challenges. Best Pract Res Clin Gastroenterol 2004 18 (Suppl 31 8.
5. Orr WC, Harnish MJ. Sleep-related gastro-oesophageal reflux: provocation with a late evening meal and treatment with acid suppression. Aliment Pharmacol Ther 1998 12:1033 1038.
6. Chey WD, Inadomi JM, Booher AM, Sharma VK, Fendrick AM, Howden CW. Primary-care physicians' perceptions and practices on the management of GERD: results of a national survey. Am J Gastroenterol 2005 100:1237 1242.
7. Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 1995 82:216 222.
8. Pare P, Meyer F, Armstrong D, Pyzyk M, Pericak D, Goeree R. Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease. Can J Gastroenterol 2003 17:307 312.
9. Rentz AM, Kahrilas P, Stanghellini V, et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res 2004 13:1737 1749.
10. Revicki DA, Rentz AM, Tack J, et al. Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders. Clin Gastroenterol Hepatol 2004 2:769 777. (Pubitemid 39200715)
11. Velanovich V, Karmy-Jones R. Measuring gastroesophageal reflux disease: relationship between the Health-Related Quality of Life score and physiologic parameters. Am Surg 1998 64:649 653.
12. Marquis P, Sapede C, Bechade D. Development and psychometric validation of a disease-specific quality of life questionnaire in gastro-oesophageal reflux. Qual Life Res 1995 5:457 458.
13. Young T. A development and validation process for a disease-specific quality of life instrument. Drug Inf J 1996 30:185 193.
14. Leidy NK, Vernon M. Perspectives on patient-reported outcomes: content validity and qualitative research in a changing clinical trial environment. Pharmacoeconomics 2008 26:363 370.
15. de la Loge C, Trudeau E, Marquis P, et al. Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res 2004 13:1751 1762.
16. Hays RD, Revicki DA. Reliability and Validity, Including Responsiveness.
17. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989 10:407 415.
18. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994 47:81 7.
19. Hays RD, Martin SA, Sesti AM, Spritzer KL. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med 2005 6:41 4.
20. Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed.
21. Samejima F. Graded Response Model. Handbook of Modern Item Response Theory.
22. Thissen D, Chen WH, Bock D. MULTILOG.
23. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951 16:297 334.
24. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989 3 (Suppl S178 89.
25. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed.
26. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008 61:102 109.
27. Wyrwich KW, Bullinger M, Aaronson N, Hays RD, Patrick DL, Symonds T. Estimating clinically significant differences in quality of life outcomes. Qual Life Res 2005 14:285 295.
28. Revicki DA, Camilleri M, Kuo B, et al. Development and content validity of a gastroparesis cardinal symptom index daily diary. Aliment Pharmacol Ther 2009 30:670 680.
29. Willis G. Cognitive Interviewing.